WallStreetZenWallStreetZen

NASDAQ: VCYT
Veracyte Inc Stock Ownership - Who owns Veracyte?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Veracyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John LeiteChief Commercial Officer-CLIA2025-03-075,011$31.96
$160.15kSell
John LeiteChief Commercial Officer-CLIA2025-03-072,400$31.04
$74.48kSell
Phillip G. FebboChief Scientific Med Officer2025-03-044,467$32.87
$146.81kSell
Annie McGuireSVP General Counsel2025-03-041,142$33.69
$38.48kSell
Phillip G. FebboChief Scientific Med Officer2025-03-043,570$33.95
$121.21kSell
Marc StapleyChief Executive Officer2025-03-041,094$34.37
$37.60kSell
Marc StapleyChief Executive Officer2025-03-0428,189$32.82
$925.25kSell
Marc StapleyChief Executive Officer2025-03-0423,414$33.91
$794.02kSell
Phillip G. FebboChief Scientific Med Officer2025-03-026,754$34.76
$234.77kSell
Annie McGuireSVP General Counsel2025-03-028,255$34.76
$286.94kSell

1 of 9

VCYT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VCYT insiders and whales buy or sell their stock.

VCYT Shareholders

What type of owners hold Veracyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc10.54%8,211,612$255.71MInstitution
Blackrock Inc9.65%7,525,314$234.34MInstitution
Artisan Partners Limited Partnership8.47%6,599,264$205.50MInstitution
Ark Investment Management LLC5.39%4,203,951$130.91MInstitution
Wellington Management Group LLP5.24%4,084,559$127.19MInstitution
Versant Ventures III LLC4.64%3,616,221$112.61MInsider
Samuel D. Colella4.64%3,616,221$112.61MInsider
Brian G. Atwood4.64%3,616,221$112.61MInsider
Brook H. Byers4.56%3,551,929$110.61MInsider
Tpg Group Holdings Sbs Advisors Inc4.56%3,551,929$110.61MInsider

1 of 3

VCYT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VCYT65.76%34.24%Net SellingNet Selling
MLTX73.62%26.38%Net Selling
ACAD71.61%28.39%Net SellingNet Selling
APLS76.79%23.21%Net SellingNet Selling
IMVT44.70%55.30%Net BuyingNet Selling
View Top Biotech Stocks

Veracyte Stock Ownership FAQ

Who owns Veracyte?

Veracyte (NASDAQ: VCYT) is owned by 105.21% institutional shareholders, 54.77% Veracyte insiders, and 0.00% retail investors. Versant Ventures III LLC is the largest individual Veracyte shareholder, owning 3.62M shares representing 4.64% of the company. Versant Ventures III LLC's Veracyte shares are currently valued at $112.61M.

If you're new to stock investing, here's how to buy Veracyte stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.